Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2/3 randomized, investigator-blinded study of NK-104 versus atorvastatin in hypercholesterolaemia
jRCT2080220211Phase 3
- Sponsor
- Kowa Company, Ltd.
- Start
- Feb 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of pitavastatin in hypercholesterolemia (2 arms), sponsored by Kowa Company, Ltd.
02
Drugs
pitavastatin
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on jRCT2080220211.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080220211.